These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 29460133)

  • 1. Effects of metformin on prostatic tissue of rats with metabolic syndrome and benign prostatic hyperplasia.
    Xu C; Xu Y; Shen Z; Zhou H; Xiao J; Huang T
    Int Urol Nephrol; 2018 Apr; 50(4):611-617. PubMed ID: 29460133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simvastatin inhibits prostatic hyperplasia in rats with metabolic syndrome.
    Gong YM; Wang X; Liu S; Hu XC; Xu Y; Huang T
    Int Urol Nephrol; 2022 Sep; 54(9):2125-2131. PubMed ID: 35691993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aerobic exercises ameliorate benign prostatic hyperplasia via IGF-1/IGF-1R/ERK/AKT signalling pathway in prostate tissue of high-fat-diet-fed mice with insulin resistance.
    Nian L; Shukang G; Shasha W; Xiangyun L
    Steroids; 2021 Nov; 175():108910. PubMed ID: 34461103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exendin-4 shows no effects on the prostatic index in high-fat-diet-fed rat with benign prostatic hyperplasia by improving insulin resistance.
    Zheng JX; Xiao YC; Hu YR; Hao M; Kuang HY
    Andrologia; 2015 Mar; 47(2):236-42. PubMed ID: 24605934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin inhibits the proliferation of benign prostatic epithelial cells.
    Wang Z; Xiao X; Ge R; Li J; Johnson CW; Rassoulian C; Olumi AF
    PLoS One; 2017; 12(3):e0173335. PubMed ID: 28253329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens.
    Monti S; Di Silverio F; Iraci R; Martini C; Lanzara S; Falasca P; Poggi M; Stigliano A; Sciarra F; Toscano V
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1700-6. PubMed ID: 11297606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin effects on biochemical recurrence and metabolic signaling in the prostate.
    Winters B; Plymate S; Zeliadt SB; Holt S; Zhang X; Hu E; Lin DW; Morrissey C; Wooldridge B; Gore JL; Porter MP; Wright JL
    Prostate; 2015 Nov; 75(15):1694-703. PubMed ID: 26201966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of epristeride on the expression of IGF-1 and TGF-beta receptors in androgen-induced castrated rat prostate.
    Wu SF; Sun HZ; Qi XD; Tu ZH
    Exp Biol Med (Maywood); 2001 Nov; 226(10):954-60. PubMed ID: 11682703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased cell proliferation and contractility of prostate in insulin resistant rats: linking hyperinsulinemia with benign prostate hyperplasia.
    Vikram A; Jena GB; Ramarao P
    Prostate; 2010 Jan; 70(1):79-89. PubMed ID: 19790233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular action of insulin-sensitizing agents].
    Kacalska O; Krzyczkowska-Sendrakowska M; Milewicz T; Zabińska-Popiela M; Bereza T; Krzysiek-Maczka G; Krzysiek J
    Endokrynol Pol; 2005; 56(3):308-13. PubMed ID: 16350724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression of insulin receptor, insulin-like growth factor increases and insulin-like growth factor-binding protein-3 reduces with increase in prostate size in benign prostatic hyperplasia.
    Sreenivasulu K; Nandeesha H; Dorairajan LN; Rajappa M; Vinayagam V; Cherupanakkal C
    Aging Male; 2018 Jun; 21(2):138-144. PubMed ID: 29129118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of Wilms' tumor gene WT-1 and elevated expression of insulin growth factor-II (IGF-II) and type 1 IGF receptor genes in prostatic stromal cells from patients with benign prostatic hyperplasia.
    Dong G; Rajah R; Vu T; Hoffman AR; Rosenfeld RG; Roberts CT; Peehl DM; Cohen P
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2198-203. PubMed ID: 9215294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pioglitazone attenuates prostatic enlargement in diet-induced insulin-resistant rats by altering lipid distribution and hyperinsulinaemia.
    Vikram A; Jena G; Ramarao P
    Br J Pharmacol; 2010 Dec; 161(8):1708-21. PubMed ID: 20726985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia.
    Cohen P; Peehl DM; Baker B; Liu F; Hintz RL; Rosenfeld RG
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1410-5. PubMed ID: 7525636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin Attenuates Testosterone-Induced Prostatic Hyperplasia in Rats: A Pharmacological Perspective.
    Mosli HH; Esmat A; Atawia RT; Shoieb SM; Mosli HA; Abdel-Naim AB
    Sci Rep; 2015 Oct; 5():15639. PubMed ID: 26492952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostatic fluid free insulin-like growth factor-1 in relation to benign prostatic hyperplasia: a controlled study.
    Ceylan C; Serel A; Doluoglu OG; Armağan A; Yüksel S
    Urol J; 2014 Jan; 10(4):1067-71. PubMed ID: 24469652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stromally expressed c-Jun regulates proliferation of prostate epithelial cells.
    Li W; Wu CL; Febbo PG; Olumi AF
    Am J Pathol; 2007 Oct; 171(4):1189-98. PubMed ID: 17702894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The underlying mechanism of metabolic syndrome on benign prostatic hyperplasia and prostate volume.
    Xia BW; Zhao SC; Chen ZP; Chen C; Liu TS; Yang F; Yan Y
    Prostate; 2020 May; 80(6):481-490. PubMed ID: 32104919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benign prostatic hyperplasia complicated with T1DM can be alleviated by treadmill exercise-evidences revealed by the rat model.
    Chen KC; Sung SY; Lin YT; Hsieh CL; Shen KH; Peng CC; Peng RY
    BMC Urol; 2015 Nov; 15():113. PubMed ID: 26576637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor.
    Kato H; Sekine Y; Furuya Y; Miyazawa Y; Koike H; Suzuki K
    Biochem Biophys Res Commun; 2015 May; 461(1):115-21. PubMed ID: 25862373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.